Innovator Takeda Pharma has sued Indian generic player Torrent Pharma in U.S. District Court for the Southern District of New York in a bid to block generic challenge on Pioglitazone Hydrochloride (Actos) 15, 30 and 45 mg tablets. Innovator Takeds in it’s complaint has asserted six patents against Torrent and has requested court to block generic approval till (June, 2016) expiry of asserted patents.
Earlier, innovator Takeda has successfully defended the invalidation bid of generic players against it’s key patent (product patent) US4687777 (Expiry: JAN 17,2011) by generic players Alphapharm and Mylan as reported by us Here and Here
Innovator Takeda got approval to market this product from USFDA on Jul 15, 1999.
For complete story please check article published in Bloomberg Here
No comments:
Post a Comment